Horowitz Benjamin A: insider trades.
Horowitz Benjamin A reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 2 open-market purchases ($24.8M) and 0 sales, across 3 companies.
- Transactions
- 6
- Purchases (P)
- 2
- Sales (S)
- 0
- Companies
- 3
- Name as filed
- HOROWITZ BENJAMIN A
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Scribe Therapeutics, Inc. (SCTX) | TenPercentOwner | 3 |
| Braveheart Bio, Inc. (BRVE) | TenPercentOwner | 2 |
| Navan, Inc. (NAVN) | Director, TenPercentOwner | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-20 | Navan, Inc. | A | 657 | $28.56 | 11,628 | Form 4 |
| 2026-08-07 | Braveheart Bio, Inc. | P | 1,100,000 | $18 | 10,232,420 | Form 4 |
| 2026-08-07 | Braveheart Bio, Inc. | C | 9,132,420 | — | 9,132,420 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | P | 333,333 | $15 | 2,385,075 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | C | 697,650 | — | 697,650 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | C | 2,051,742 | — | 2,051,742 | Form 4 |
Questions
What stock did Horowitz Benjamin A buy or sell?
Horowitz Benjamin A reported 6 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 2 open-market purchases ($24.8M) and 0 sales, across 3 companies.
Is Horowitz Benjamin A the same person as other filers with this name?
This page covers SEC CIK 1166586 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/horowitz-benjamin-a-1166586.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.